Evaluation of low density lipoprotein oxidation in a course of hypothyroidism;Ocena oksydacji lipoprotein małej gȩstości w przebiegu niedoczynności tarczycy

Endokrynologia Polska

Volumn 57, Issue 2, 2006, Pages 116-121

  Lampka, Magdalena ^a   Junik, Roman ^a   Nowicka, Anna ^a   Kardymowicz, Hanna ^b   Kaczorowski, Piotr ^a   Tyrakowski, Tomasz ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b Regional Oncology Centre Bydgoszcz   (Poland)

Author keywords

Antibodies against oxidized LDL; Hypothyroidism; Lipoprotein oxidation; Oxidized LDL

Indexed keywords

ANTIBODY; BIOLOGICAL MARKER; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; BLOOD; COMPARATIVE STUDY; FEMALE; HUMAN; HYPOTHYROIDISM; IMMUNOLOGY; MALE; MIDDLE AGED; REFERENCE VALUE;

ADULT; AGED; ANTIBODIES; BIOLOGICAL MARKERS; FEMALE; HUMANS; HYPOTHYROIDISM; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; REFERENCE VALUES;

EID: 39049176786     PISSN: 0423104X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Cappola AR, Ladenson PW. Hypothyroidism and atherosclerosis. J Clin Endocrinol Metab 2003; 88: 2438-2444. (Pubitemid 36724408)
2. Diekman T, Demacker PN, Kastelein JJ i wsp. Increased oxidi-zability of low-density lipoproteins in hypothyroidism. J Clin Endocrinol Metab 1998; 83: 1752-1755. (Pubitemid 28501053)
3. Duntas LH. Thyroid disease and lipids. Thyroid 2002; 12: 287-293. (Pubitemid 34438931)
4. Oge A, Sozmen E, Karaoglu AO. Effect of thyroid function on LDL oxidation in hypothyroidism and hyperthyroidism. En-docr Res 2004; 30: 481-489. (Pubitemid 39453094)
5. Sundaram V, Hanna AN, Koneru L i wsp. Both hypothyro-idism and hyperthyroidism enhance low density lipoprotein oxidation. J Clin Endocrinol Metab 1997; 82: 3421-3424. (Pubitemid 27419098)
6. Duntas LH, Mantzou E, Koutras DA. Circulating levels of oxidized low-density lipoprotein in overt and mild hypothyro-idism. Thyroid 2002; 12: 1003-1007. (Pubitemid 35404135)
7. Laurman W. Modified low density lipoproteins in the patho-genesis of atherosclerosis. Int J Occup Med Environ Health 1994; 7: 65-76. (Pubitemid 24242217)
8. Constantini F, Pierdomenico SD, de Cesare D i wsp. Effect of thyroid function on LDL oxidation. Arterioscler Thromb Vasc Biol 1998; 18: 732-737. (Pubitemid 28267652)
9. Dumitriu L, Bartoc R, Ursu H i wsp. Significance of high levels of serum malonodialdehyde (MDA) and ceruloplasmin (CP) in hyper-and hypothyroidism. Rev Roum Med Endocrinol 1988; 26: 35-38.
10. Resch U, Helsel G, Tatzber F, Sinzinger H. Antioxidant status in thyroid dysfunction. Clin Chem Lab Med 2002; 40: 1132-1134. (Pubitemid 36024447)
11. Konukoglu D, Ercan M, Hatemi H. Plasma viscosity in female patients with hypothyroidism: Effects of oxidative stress and cholesterol. Clin Hemorheol Microcirc 2002; 27: 107-113. (Pubitemid 35024998)
12. Hanna AN, Titterington LC, Lantry LE i wsp. Thyronines and Probucol inhibition of human capillary endothelial cell-inducted low density lipoprotein oxidation. Biochem Pharmacol 1995; 50: 1627-1633.
13. Salonen JT, Ylä-Herttuala S, Yamamoto R i wsp. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet 1992; 339: 883-887.
14. Bergmark C, Wu R, de Faire U i wsp. Patients with early-onset peripheral vascular disease have increased levels of auto-antibodies against oxidized LDL. Arterioscler Thromb Vasc Biol 1995; 15: 441-445.
15. Bellomo G, Maggi E, Poli M i wsp. Autoantibodies against oxi-datively modified low-density lipoproteins in NIDDM. Diabetes 1995; 44: 60-66.
16. Fukumoto M, Shoji T, Emoto M i wsp. Antibodies against oxidized LDL and carotid artery intima-media thickness in a healthy population. Arterioscler Thromb Vasc Biol 2000; 20: 703-707. (Pubitemid 30151684)
17. van de Vijver LP, Steyger R, van Poppel G i wsp. Antibodies against MDA-LDL in subjects with severe and minor atherosclerosis and healthy population controls. Atherosclerosis 1996; 122: 245-253. (Pubitemid 26156726)
18. Steinerová A, Racek J, Stožický F i wsp. Antibodies against oxidized LDL-Theory and Clinical Use. Physiol Res 2001; 50: 131-141. (Pubitemid 32523435)